EntreMed Inc  

(Public, NASDAQ:ENMD)   Watch this stock  
Find more results for ENMD
1.87
-0.05 (-2.60%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.85 - 1.90
52 week 1.45 - 2.38
Open 1.89
Vol / Avg. 11,742.00/24,311.00
Mkt cap 50.57M
P/E     -
Div/yield     -
EPS -0.22
Shares 27.04M
Beta 1.56
Inst. own 12%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -33.04% -46.87%
Return on average equity -34.19% -49.52%
Employees 8 -
CDP Score - -

Address

Suite 300, 9620 Medical Center
ROCKVILLE, MD 20850
United States - Map
+1-240-8642600 (Phone)
+1-301-3152437 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company. EntreMed's drug candidate is ENMD-2076, an Aurora A and angiogenic kinase inhibitor for the treatment of cancer. ENMD-2076 has completed Phase I studies in patients with advanced solid tumors, multiple myeloma and leukemia and is completing data for a multi-center Phase II study in patients with platinum resistant ovarian cancer. The Company´┐Żs other product candidates have includes MKC-1, ENMD-1198 and 2-methoxyestrdiol (2ME2, Panzem) for treatment of rheumatoid arthritis. ENMD-2076 is a novel orally-active, Aurora A/angiogenic kinase inhibitor with potent activity against Aurora A and multiple tyrosine kinases linked to cancer and inflammatory diseases.

Officers and directors

Wei-Wu He Ph.D. Executive Chairman of the Board
Age: 48
Bio & Compensation  - Reuters
Ken K. Ren Ph.D. Chief Executive Officer
Age: 54
Bio & Compensation  - Reuters
Wong Hu J.D. Chief Operating Officer, General Counsel, Secretary
Age: 43
Bio & Compensation  - Reuters
Sara B. Capitelli CPA Vice President - Finance, Principal Accounting Officer
Age: 46
Bio & Compensation  - Reuters
Tak W. Mak Ph.D. Director
Age: 67
Bio & Compensation  - Reuters
James Z. Huang Independent Director
Bio & Compensation  - Reuters
Jennie C. Hunter-Cevera Ph.D. Independent Director
Age: 65
Bio & Compensation  - Reuters
Y. Alexander Wu Ph.D. Independent Director
Age: 49
Bio & Compensation  - Reuters